Statistics for Apontis Pharma AG (id:2859 APPH)
Valuation metrics
Market cap
85.85M
Enterprise value
67.56M
Trailing P/E (ttm)
17.88
Forward P/E
21.96
PEG ratio
21.96
Price/Sales (ttm)
2.11
Price/Book (mrq)
2.72
Enterprise Value/Revenue
1.66
Enterprise Value/EBITDA
-43.05
Overview
Shares outstanding
8.50M
Float
5.10M
Shares short
% Held by insiders
0.00%
% Held by institutions
3.00%
Average volume (10 days)
10.24K
Average volume (90 days)
Price summary
52-Week low
4.12
52-Week high
10.10
52-Week change
53.86%
Beta
1.24
50-Day moving average
9.61
200-Day moving average
8.25
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
June 30, 2024
Profitability
Profit margin
-17.42%
Operating margin
4.31%
Operational effectiveness
Return on assets
-4.51%
Return on equity
-20.52%
Income statement
Revenue (ttm)
4.88
Revenue per share (ttm)
4.88
Quarterly revenue growth (yoy)
Gross profit (ttm)
23.17M
EBITDA
-1,569,372.00
Net income to common (ttm)
-7,078,684.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
16.16M
Total cash per share (mrq)
1.94
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
195.60%
Book value per share (mrq)
3.72
Cash flow
Cash flow statement
-7,495,046.00
Levered free cash flow (LFCF)
-2,726,347.00